En español
NIDA

Menu

Heroin: Abuse and Addiction

References

  1. Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse, Vol. II, Proceedings of the Community Epidemiology Work Group, December 2003. NIH Pub. No. 04-5365. Bethesda, MD: NIDA, NIH, DHHS, 2004.
  2. Dashe, J.S.; Jackson, G.L.; Olscher, D.A.; Zane, E.H.; and Wendel, G.D., Jr. Opioid detoxification in pregnancy. Obstet Gynecol 92(5):854-858, 1998.
  3. Dole, V.P.; Nyswander, M.E.; and Kreek, M.J. Narcotic blockade. Arch Intern Med 118(4):304-309, 1966.
  4. Goldstein, A. Heroin addiction: Neurology, pharmacology, and policy. J Psychoactive Drugs 23(2):123-133, 1991.
  5. Hughes, P.H.; and Rieche, O. Heroin epidemics revisited. Epidemiol Rev 17(1):66-73, 1995.
  6. Hulse, G.K.; Milne, E.; English, D.R.; and Holman, C.D.J. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 92(11):1571-1579, 1997.
  7. Jansson, L.M.; Svikis, D.; Lee, J.; Paluzzi, P.; Rutigliano, P.; and Hackerman, F. Pregnancy and addiction; a comprehensive care model. Journal of Substance Abuse Treatment 13(4):321-329, 1996.
  8. Jarvis, M.A.; and Schnoll, S.H. Methadone use during pregnancy. NIDA Research Monograph 149, 58-77, 1995.
  9. Johnson, R.E.; Jones, H.E.; and Fischer, G. Use of buprenorphine in pregnancy: patient management and effects on neonate. Drug and Alcohol Dependence 70(2):S87-S101, 2003.
  10. Jones, H.E. Practical Considerations for the Clinical Use of Buprenorphine. Science & Practice Perspectives 2(2):4-20, 2004.
  11. Kornetsky, C. Action of opioid on the brain-reward system. In: Rapaka, R.S.; and Sorer, H.; eds. Discovery of Novel Opioid Medications. National Institute on Drug Abuse Research Monograph 147. NIH Pub. No. 95-3887. Washington, DC: Supt. of Docs., U.S. Govt. Print Off., 1991, pp. 32-52.
  12. Kreek, M.J. Using methadone effectively: Achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs. In: Pickens, R.; Leukefeld, C.; and Schuster, C.R.; eds. Improving Drug Abuse Treatment. National Institute on Drug Abuse Research Monograph 106. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1991, pp. 245-266.
  13. Lewis, J.W.; and Walter, D. Buprenorphine: Background to its development as a treatment for opiate dependence. In: Blaine, J.D., ed. Buprenorphine: An Alternative for Opiate Dependence. National Institute on Drug Abuse Research Monograph 121. DHHS Pub. No. (ADM) 92-1912. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1992, pp. 5-11.
  14. Luty, J.; Nikolaou, V.; and Bearn, J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 24(4):363-367, 2003.
  15. Maas, U.; Kattner, E.; Weingart-Jesse, B.; Schafer, A.; and Obladen, M. Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med 18(2):111-118, 1990.
  16. Mathias, R. NIDA survey provides first national data on drug abuse during pregnancy. NIDA NOTES 10:6-7, 1995.
  17. Messinger, D.S.; Bauer, C.R.; Das, A.; Seifer, R.; Lester, B.M.; Lagasse, L.L.; Wright, L.L.; Shankaran, S.; Bada, H.S.; Smeriglio, V.L.; Langer, J.C.; Beeghly, M.; and Poole, W.K. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 113(6):1677-1685, 2004.
  18. National Institute on Drug Abuse. "Heroin." NIDA Capsule. NIDA, 1986.
  19. National Institute on Drug Abuse. IDUs and infectious diseases. NIDA NOTES 9:15, 1994.
  20. National Institute on Drug Abuse. Monitoring the Future, National Results on Adolescent Drug Use, Overview of Key Findings 2004. NIH Pub. No. 05-5726. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 2005.
  21. Novick, D.M.; Richman, B.L.; Friedman, J.M.; Friedman, J.E.; Fried, C.; Wilson, J.P.; Townley, A.; and Kreek, M.J. The medical status of methadone maintained patients in treatment for 11-18 years. Drug and Alcohol Depend 33(3):235-245, 1993.
  22. Office of Applied Studies. Results from the 2003 National Survey on Drug Use and Health: National Findings. DHHS Pub. No. (SMA) 04-3964. SAMHSA, 2004.
  23. Office of National Drug Control Policy. Heroin Facts and Figures. Rockville, MD, 2004. Available at www.whitehousedrugpolicy.gov/drugfact/heroin/index.html.
  24. Sobel, K. NIDA's AIDS projects succeed in reaching drug addicts, changing high-risk behaviors. NIDA NOTES 6:25-27, 1991.
  25. Substance Abuse and Mental Health Services Administration Office of Applied Studies. Emergency Department Trends From the Drug Abuse Warning Network, Final Estimates 1995-2002. DHHS Pub. No. (SMA) 63-3780. Rockville, MD: SAMHSA, 2003.
  26. Swan, N. Research demonstrates long-term benefits of methadone treatment. NIDA NOTES 9:1, 4-5, 1994.
  27. Woods, J.H.; France, C.P.; and Winger, G.D. Behavioral pharmacology of buprenorphine: Issues relevant to its potential in treating drug abuse. In: Blain, J.D., ed. Buprenorphine: An Alternative for Opiate Dependence. National Institute on Drug Abuse Research Monograph 121. DHHS Pub. No. (ADM) 92-1912. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1992, pp. 12-27.

This page was last updated May 2005

Attention

Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

Looking for Treatment?

Use the SAMHSA Treatment Locator or 1-800-662-HELP.

Helpline open during government shutdown

​Research Reports

This series of reports simplifies the science of research findings for the educated lay public, legislators, educational groups, and practitioners. The series reports on research findings of national interest.

Featured Publication

Featured Publication

Drugs, Brains, and Behavior - The Science of Addiction

As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.

Ordering Publications

Call 1-877-643-2644 or:

NIDA Drug Pubs